Share Prices & Company Research

Stockbroking

Hikma Pharmaceuticals

Current Price 2282.00p Bid 2281.00p Ask 2284.00p Change -2.89%
Last Updated: 11/05/2021 12:05. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Financial Highlights Year Ended 31/12/2020

Revenue
£2,341.00m
Operating Profit/Loss
£579.00m
Dividend yield (%)
1.40
Total dividend for year
$n/a
Dividend cover
3.46
P/E Ratio
20.60

Key Personnel

Mr Sigurdur Olafsson
Chief Executive Officer
Ms Peter Speirs
Company Secretary
Mr Said Darwazah
Executive Chairman
Mr Mazen Darwazah
Executive Vice Chairman
Dr Pamela Kirby
Independent Non-Executive Director
Mr Douglas Hurt
Independent Non-Executive Director
Mr John J. Castellani
Independent Non-Executive Director
Mr Pat Butler
Independent Non-Executive Director
Mrs Cynthia Schwalm
Independent Non-Executive Director
Ms Mary (Nina) Henderson
Independent Non-Executive Director
Mr Ali Al-Husry
Non-Executive Director

Stock Details

EPIC
HIKL
ISIN
GB00B0LCW083
Shares in Issue
199.39m
Market cap
£4,549.97m

Analyst Views (2)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
2,282.00p
Bid Price
2,281.00p
Ask Price
2,284.00p
Volume
12,832
Change Today
-68.00p
% Change Today
-2.89%
Open
2,341.00p
Previous Close
2,350.00p
Intraday High
2,354.00p
Intraday Low
2,282.00p
52 Week High
2,695.00p
52 Week Low
2,094.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Income Statement

Year End Date
31 Dec 2020
31 Dec 2019
 
$ (M)
$ (M)
Continuing Operations
Revenue
2,341.00
2,207.00
Operating Profit/Loss
579.00
493.00
Net Interest
-22.00
n/a
Pre-Tax Profit
558.00
491.00
Profit After Tax from continuing operations
430.00
487.00
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
430.00
487.00
Attributable to:
Equity Holders of Parent Company
431.00
486.00
Minority Interests
-1.00
1.00
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2020
31 Dec 2019
Basic
182.60c
200.80c
Diluted
181.10c
200.00c
Adjusted
172.90c
150.40c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2020
31 Dec 2019
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
1,068.00
962.00
Intangible Assets
876.00
834.00
Investment Properties
n/a
n/a
Investments
9.00
11.00
Other Financial Assets
n/a
n/a
Other Non-Current Assets
260.00
275.00
Current Assets
Inventories
757.00
568.00
Trade & Other Receivables
756.00
719.00
Cash at Bank & In Hand
323.00
442.00
Current Asset Investments
n/a
n/a
Other Current Assets
86.00
119.00
Other Assets
n/a
n/a
Total Assets
4,135.00
3,930.00

Liabilities

Year End Date
31 Dec 2020
31 Dec 2019
 
$ (M)
$ (M)
Current Liabilities
Borrowings
168.00
578.00
Other Current Liabilities
860.00
893.00
Total Current Liabilities
1,028.00
1,471.00
Non-Current Liabilities
Borrowings
764.00
107.00
Provisions
31.00
20.00
Other Non-Current Liabilities
164.00
203.00
Total Non-Current Liabilities
959.00
330.00
Other Liabilities
n/a
n/a
Total Liabilities
1,987.00
1,801.00

Net Assets

Year End Date
31 Dec 2020
31 Dec 2019
 
$ (M)
$ (M)
Net Assets
2,148.00
2,129.00

Capital & Reserves

Year End Date
31 Dec 2020
31 Dec 2019
 
$ (M)
$ (M)
Share Capital
41.00
41.00
Share Premium Account
282.00
282.00
Other Reserves
-80.00
-179.00
Retained Earnings
1,892.00
1,973.00
Shareholders Funds
2,135.00
2,117.00
Minority Interests/Other Equity
13.00
12.00
Total Equity
2,148.00
2,129.00

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Final
18 Mar 2021
26 Apr 2021
34.00¢
Interim
20 Aug 2020
21 Sep 2020
16.00¢
Final
19 Mar 2020
07 May 2020
30.00¢
Interim
22 Aug 2019
23 Sep 2019
14.00¢
Final
04 Apr 2019
22 May 2019
26.00¢
Interim
23 Aug 2018
21 Sep 2018
12.00¢
Final
05 Apr 2018
24 May 2018
23.00¢
Interim
24 Aug 2017
22 Sep 2017
11.00¢
Final
06 Apr 2017
25 May 2017
22.00¢
Interim
01 Sep 2016
30 Sep 2016
11.00¢
Final
07 Apr 2016
19 May 2016
21.00¢
Interim
27 Aug 2015
25 Sep 2015
11.00¢
Special
16 Apr 2015
21 May 2015
6.00¢
Special
16 Apr 2015
21 May 2015
6.00¢

Dividend Metrics

Year End Date
31 Dec 2020
31 Dec 2019
Dividend growth
13.64%
15.79%
Dividend yield
1.40%
1.60%
Dividend cover
3.46
3.42


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.